Literature DB >> 32267317

Discordance of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol with Severity of Coronary Artery Disease.

Iran Castro1, Hugo Fontana Filho1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32267317      PMCID： PMC7792721          DOI： 10.36660/abc.20200033

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN： 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  7 in total

Review 1.  Lipid parameters for measuring risk of cardiovascular disease.

Authors:  Benoit J Arsenault; S Matthijs Boekholdt; John J P Kastelein
Journal:  Nat Rev Cardiol       Date:  2011-02-01       Impact factor: 32.419

2.  Lomitapide, relief pitcher for patients with homozygous familial hypercholesterolemia.

Authors:  Sang-Hyun Kim; Sang Hong Baek
Journal:  Eur J Prev Cardiol       Date:  2019-10-11       Impact factor: 7.804

3.  Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.

Authors:  Laszlo Mark; Antonio J Vallejo-Vaz; Istvan Reiber; György Paragh; Sreenivasa Rao Kondapally Seshasai; Kausik K Ray
Journal:  Atherosclerosis       Date:  2015-04-30       Impact factor: 5.162

4.  Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study.

Authors:  Allan D Sniderman; Shofique Islam; Salim Yusuf; Matthew J McQueen
Journal:  Atherosclerosis       Date:  2012-09-23       Impact factor: 5.162

Review 5.  Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.

Authors:  Michael G Silverman; Brian A Ference; Kyungah Im; Stephen D Wiviott; Robert P Giugliano; Scott M Grundy; Eugene Braunwald; Marc S Sabatine
Journal:  JAMA       Date:  2016-09-27       Impact factor: 56.272

Review 6.  Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.

Authors:  Brian A Ference; Henry N Ginsberg; Ian Graham; Kausik K Ray; Chris J Packard; Eric Bruckert; Robert A Hegele; Ronald M Krauss; Frederick J Raal; Heribert Schunkert; Gerald F Watts; Jan Borén; Sergio Fazio; Jay D Horton; Luis Masana; Stephen J Nicholls; Børge G Nordestgaard; Bart van de Sluis; Marja-Riitta Taskinen; Lale Tokgözoglu; Ulf Landmesser; Ulrich Laufs; Olov Wiklund; Jane K Stock; M John Chapman; Alberico L Catapano
Journal:  Eur Heart J       Date:  2017-08-21       Impact factor: 29.983

7.  Discordance of Low-Density Lipoprotein Cholestrol and Non-High-Density Lipoprotein Cholestrol and Coronary Artery Disease Severity.

Authors:  Ozge Kurmus; Aycan Fahri Erkan; Berkay Ekici; Turgay Aslan; Murat Eren
Journal:  Arq Bras Cardiol       Date:  2020-03       Impact factor: 2.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.